Mahdi Razafsha — TMS Medicare billing

MD · Psychiatry · Boston, MA

NPI 1912293689
23 · Low
NPI registry

TMS provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Services (2024)

430

Patient bounds

37–37

Services per patient (bounds)

11.6–11.6

Estimated Medicare paid

$74,305

National provider median $51,810

National peer context

#19 of 391 published TMS providers by screening score/payment in 2024 · 0.21% of national published TMS payment. This rank is not a clinical assessment.

Peer evidence

Screening score 23 · Low; highest same-code/setting shared peer score, not a probability of fraud.

90868 · Facility · Patient count above 99th percentile of peers: 37.00 vs peer median 15.00 · 32 peers (Psychiatry).

No NPI match in the saved OIG LEIE copy—not a clearance.

Year-over-year Medicare payments

CMS billing detail — 2024

Fetched 2026-11-07T23:23:37.341Z · Complete three-code cohort

Code / treatmentServicesPatient boundsServices / patientMedicare paid
90868

Subsequent treatment

43037–3711.6–11.6$74,305

Peer evidence

Screening score 23 · Low; highest same-code/setting shared peer score, not a probability of fraud.

90868 · Facility · Patient count above 99th percentile of peers: 37.00 vs peer median 15.00 · 32 peers (Psychiatry).

CMS billing detail — 2023

Fetched 2026-11-07T23:23:27.130Z · Complete three-code cohort

Code / treatmentServicesPatient boundsServices / patientMedicare paid
90868

Subsequent treatment

64339–3916.5–16.5$111,618

Peer evidence

Screening score Not scored; highest same-code/setting shared peer score, not a probability of fraud.

Insufficient or incomplete peer evidence—no score assigned.

Medicare Part B fee-for-service only; Medicare Advantage, Medicaid and commercial claims are excluded. CMS suppresses provider-code rows with fewer than 11 beneficiaries. Patient counts overlap across codes and settings; bounds are not unique national patients. Annual aggregates cannot establish treatment courses, failure, medical necessity, duplicate visits or fraud. Coverage varies by Medicare contractor; no Spravato dosing thresholds are applied.